NYT: US to stop production of AstraZeneca vaccine

The administration of US President Joe Biden has decided to stop production of the AstraZeneca vaccine at the Emergent Biosolutions plant in Baltimore, Maryland. The newspaper The New York Times reports.

According to newspaper sources, the US authorities made this decision after 15 million doses of Johnson & Johnson vaccine were spoiled due to an error that resulted in the mixing of components from the two manufacturers.

“The Johnson & Johnson vaccine, in contrast to the AstraZeneca drug, is a one-component, in addition, the American company already at the end of February received approval from the US Food and Drug Administration (FDA) to use its vaccine, while the AstraZeneca drug has not yet approved for use in the United States”, – writes The New York Times.

It also reported that AstraZeneca’s management is currently in talks with the Biden administration to find a new site to produce its version of the vaccine. A company spokesman said that vaccine production at the Baltimore plant will not stop until the plant receives a new version of the contract.

Comments:

comments powered by HyperComments